1072919-85-7

Basic information

• Product Name: 4-amino-3,5-dinitro-benzoyl chloride
• Synonyms: 4-amino-3,5-dinitro-benzoyl chloride
• CAS NO: 1072919-85-7
• Molecular Weight: 245.579
• Mol File: 1072919-85-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-amino-3,5-dinitro-benzoyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 4-amino-3,5-dinitro-benzoyl chloride(1072919-85-7)
• EPA Substance Registry System: 4-amino-3,5-dinitro-benzoyl chloride(1072919-85-7)

Safety Data

• Hazardous Substances Data: 1072919-85-7(Hazardous Substances Data)

Upstream product

• 7221-27-4 4-amino-3,5-dinitrobenzoic acid 
• 54321-79-8 4-amino-3,5-dinitrobenzamide 

Downstream Products

• 1434143-17-5 7-amino-2-phenyl-5-(tert-butoxycarbonylamino)-1H-benzo[d]imidazole 
• 1434143-16-4 4-amino-3,5-dinitro-1-(tert-butoxycarbonylamino)benzene 
• 1259926-65-2 C₁₈H₁₈N₄O₄ 
• 130145-45-8 4-amino-3,5-dinitro-1-(methoxycarbonylamino)benzene 
• 130145-46-9 methyl (3,4,5-triaminophenyl)carbamate 
• 1072919-64-2 7-amino-2-(3-fluorophenyl)-5-methoxycarbonylamino-1H-benzo[d]imidazole 
• 1259926-67-4 7-amino-2-(3,5-dimethylphenyl)-5-ethoxycarbonylamino-1H-benzo[d]imidazole 
• 1259926-66-3 7-amino-2-(4-bromophenyl)-5-ethoxycarbonylamino-1H-benzo[d]imidazole 
• 1072919-62-0 7-amino-5-ethoxycarbonylamino-2-phenyl-1H-benzo[d]imidazole 
• 1259926-64-1 7-amino-2-(2,4-dimethoxyphenyl)-5-ethoxycarbonylamino-1H-benzo[d]imidazole 
• 1259926-63-0 4-amino-3,5-dinitro-1-(ethoxycarbonylamino)benzene 
• 1072919-83-5 7-acetylamino-5-ethoxycarbonylamino-2-phenyl-1H-benzo-[d]imidazole 

Relevant articles and documents

Benzimidazole-based antibacterial agents against Francisella tularensis

Francisella tularensis is a highly virulent pathogenic bacterium. In order to identify novel potential antibacterial agents against F. tularensis, libraries of trisubstituted benzimidazoles were screened against F. tularensis LVS strain. In a preliminary

BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF

The present invention relates to novel benzimidazole derivatives and pharmaceutically acceptable salts thereof. Another aspect of the invention relates to methods of treating a patient infected by Mycobacterium tuberculosis or Francisella tulerensis by ad